Fibrin directs early retinal damage after experimental subretinal hemorrhage
- PMID: 2025175
- DOI: 10.1001/archopht.1991.01080050139046
Fibrin directs early retinal damage after experimental subretinal hemorrhage
Abstract
Subretinal blood within the macula may cause visual loss in a number of macular diseases. The clinical and histopathologic effects of experimental subretinal hemorrhage were evaluated in the cat. Subretinal hemorrhages were produced by creating a focal neurosensory retinal detachment with micropipette techniques, then inserting a needle tip transsclerally to allow choroidal blood to fill the bleb. Experimental lesions were examined clinically and with light and electron microscopy during a 14-day postoperative period. Initial observations included clot organization with retraction of fibrin strands. In six of nine clots more than 1 hour old, fibrin was associated with tearing of sheets of photoreceptor inner and outer segments. Later degeneration progressed to involve all retinal layers overlying the densest areas of fibrin in the clots. Hemorrhages into subretinal blebs containing tissue plasminogen activator did not form fibrin strands or cause photoreceptor tearing. These findings highlight the potential for improved retinal survival if organized subretinal clot can be eliminated soon after formation.
Similar articles
-
Fibrinolytic-assisted removal of experimental subretinal hemorrhage within seven days reduces outer retinal degeneration.Ophthalmology. 1994 Apr;101(4):672-81. doi: 10.1016/s0161-6420(94)31279-6. Ophthalmology. 1994. PMID: 8152762
-
Ultramicrosurgical removal of subretinal hemorrhage in cats.Am J Ophthalmol. 1992 Feb 15;113(2):175-82. doi: 10.1016/s0002-9394(14)71530-2. Am J Ophthalmol. 1992. PMID: 1550185
-
Experimental subretinal hemorrhage in rabbits.Am J Ophthalmol. 1982 Dec;94(6):762-73. doi: 10.1016/0002-9394(82)90301-4. Am J Ophthalmol. 1982. PMID: 7180915
-
Pathophysiology and management of subretinal hemorrhage.Surv Ophthalmol. 1997 Nov-Dec;42(3):195-213. doi: 10.1016/s0039-6257(97)00089-1. Surv Ophthalmol. 1997. PMID: 9406367 Review.
-
[Pathophysiology of macular diseases--morphology and function].Nippon Ganka Gakkai Zasshi. 2011 Mar;115(3):238-74; discussion 275. Nippon Ganka Gakkai Zasshi. 2011. PMID: 21476310 Review. Japanese.
Cited by
-
Functional and structural outcome after vitrectomy combined with subretinal rtPA Injection with or without additional intravitreal Bevacizumab injection for submacular hemorrhages.PLoS One. 2021 Apr 30;16(4):e0250587. doi: 10.1371/journal.pone.0250587. eCollection 2021. PLoS One. 2021. PMID: 33930041 Free PMC article.
-
An Innovatory Surgical Technique for Submacular Hemorrhage Displacement by Means of a Bioengineering Perspective.Vision (Basel). 2021 May 18;5(2):23. doi: 10.3390/vision5020023. Vision (Basel). 2021. PMID: 34069949 Free PMC article.
-
[Combined intravitreal injection of bevacizumab and SF6 gas for treatment of submacular hemorrhage secondary to age-related macular degeneration].Ophthalmologe. 2010 Apr;107(4):328-32. doi: 10.1007/s00347-009-2004-3. Ophthalmologe. 2010. PMID: 19669150 Clinical Trial. German.
-
Traumatic submacular hemorrhage: available treatment options and synthesis of the literature.Int J Retina Vitreous. 2019 Dec 11;5:48. doi: 10.1186/s40942-019-0200-0. eCollection 2019. Int J Retina Vitreous. 2019. PMID: 31890278 Free PMC article. Review.
-
Treatment of macular hemorrhage in retinal arterial microaneurysm: anatomic site-oriented therapy.Jpn J Ophthalmol. 2019 Mar;63(2):186-196. doi: 10.1007/s10384-019-00653-y. Epub 2019 Feb 19. Jpn J Ophthalmol. 2019. PMID: 30783941
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous